Viewing Study NCT00492505


Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2026-01-27 @ 2:34 AM
Study NCT ID: NCT00492505
Status: UNKNOWN
Last Update Posted: 2014-01-10
First Post: 2007-06-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Sponsor: San Diego Pacific Oncology & Hematology Associates
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module